Caggiano, Christa
Boudaie, Arya
Shemirani, Ruhollah
Mefford, Joel
Petter, Ella
Chiu, Alec
Ercelen, Defne
He, Rosemary
Tward, Daniel
Paul, Kimberly C.
Chang, Timothy S.
Pasaniuc, Bogdan
Kenny, Eimear E.
Shortt, Jonathan A. http://orcid.org/0000-0002-7980-5420
Gignoux, Christopher R.
Balliu, Brunilda
Arboleda, Valerie A.
Belbin, Gillian
Zaitlen, Noah http://orcid.org/0000-0002-3553-3670
Article History
Received: 12 July 2022
Accepted: 30 May 2023
First Online: 18 July 2023
Competing interests
: C.R.G. owns stock in 23andMe, Inc. E.E.K. has received personal fees from Regeneron Pharmaceuticals, 23andMe, Allelica and Illumina; has received research funding from Allelica; and serves on the advisory boards for Encompass Biosciences, Overtone and Galateo Bio. All other authors declare no competing interests.